Research graph
References from The natural history of diabetes‐related complications: the UKPDS experience. Local targets link to admitted publications; unresolved targets remain external evidence.
A study of the effects of hypoglycemic agents on vascular complications in patients with adult‐onset diabetes. II. Mortality results.
1970 · External reference
Effects of hypoglycemic agents on vascular complications in patients with adult‐onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment.
10.1001/jama.1978.03290010041020 · 1978 · External reference
10.2337/diab.25.12.1129
10.2337/diab.25.12.1129 · External reference
Some answers, more controversy, from UKPDS.
1998 · External reference
10.1055/s-0029-1212000
10.1055/s-0029-1212000 · External reference
Implications of the United Kingdom Prospective Diabetes Study.
1999 · External reference
10.1016/0168-8227(95)01064-k
10.1016/0168-8227(95)01064-k · External reference
10.1001/archinte.1997.00440230053007
10.1001/archinte.1997.00440230053007 · External reference
Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (ukpds 33).
1998 · External reference
10.1016/s0140-6736(98)07037-8
10.1016/s0140-6736(98)07037-8 · External reference
Unresolved reference
External reference
10.1016/s0168-8227(98)00038-2
10.1016/s0168-8227(98)00038-2 · External reference
10.2337/diacare.21.3.c35
10.2337/diacare.21.3.c35 · External reference
The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus.
10.1056/nejm199309303291401 · 1993 · External reference
10.2337/diabetes.46.2.271
10.2337/diabetes.46.2.271 · External reference
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes.
10.1136/bmj.317.7160.703 · 1998 · External reference
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabeteS.
10.1136/bmj.317.7160.713 · 1998 · External reference
10.1136/bmj.317.7160.720
10.1136/bmj.317.7160.720 · External reference
10.1136/bmj.310.6987.1109
10.1136/bmj.310.6987.1109 · External reference
10.1136/bmj.312.7041.1274
10.1136/bmj.312.7041.1274 · External reference
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease.
1997 · External reference
10.2337/diacare.21.12.2180
10.2337/diacare.21.12.2180 · External reference
VIII. Study design, progress and performance.
1991 · External reference
10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s · External reference
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
1999 · External reference
10.1136/bmj.317.7160.691
10.1136/bmj.317.7160.691 · External reference
10.1136/bmj.317.7160.693
10.1136/bmj.317.7160.693 · External reference
10.1002/(sici)1096-9136(1998110)15:11<895::aid-dia751>3.0.co;2-z
10.1002/(sici)1096-9136(1998110)15:11<895::aid-dia751>3.0.co;2-z · External reference
10.1046/j.1463-1326.1999.00009.x · Admitted local publication
